All changes for the tissue urogenital system (236)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA620
Hypertensive heart and renal disease
Pathological
heart, kidney
Human
—
SeriesMorbidity
DAA285
immunoglobulin kappa variable 1-5
Molecular
kidney
Human
IGKV1-5
35.0% Increase Gene Expression Level
DAA278
Ras-related GTP binding D
Molecular
kidney
Human
RRAGD
14.0% Decrease Gene Expression Level
DAA2020
Reduction in renal function
Physiological
kidney
Human
—
—
DAA640
Renal failure
Pathological
kidney
Human
—
SeriesMorbidity
DAA276
Rh family, C glycoprotein
Molecular
kidney
Human
RHCG
16.0% Decrease Gene Expression Level
DAA880
Kidney mass gradually lost
Physiological
kidney
Human
—
—
DAA639
Kidney diseases
Pathological
kidney
Human
—
SeriesMorbidity
DAA269
alpha-kinase 2
Molecular
kidney
Human
ALPK2
20.0% Increase Gene Expression Level
DAA267
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein
Molecular
kidney
Human
APBB1IP
23.0% Increase Gene Expression Level
DAA604
Cancer of kidney and renal pelvis
Pathological
urinary system
Human
—
SeriesMorbidity
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA620 | Hypertensive heart and renal disease | Pathological | heart, kidney | Human | — | SeriesMorbidity | |
DAA285 | immunoglobulin kappa variable 1-5 | Molecular | kidney | Human | IGKV1-5 | 35.0% Increase Gene Expression Level | |
DAA278 | Ras-related GTP binding D | Molecular | kidney | Human | RRAGD | 14.0% Decrease Gene Expression Level | |
DAA2020 | Reduction in renal function | Physiological | kidney | Human | — | — | |
DAA640 | Renal failure | Pathological | kidney | Human | — | SeriesMorbidity | |
DAA276 | Rh family, C glycoprotein | Molecular | kidney | Human | RHCG | 16.0% Decrease Gene Expression Level | |
DAA880 | Kidney mass gradually lost | Physiological | kidney | Human | — | — | |
DAA639 | Kidney diseases | Pathological | kidney | Human | — | SeriesMorbidity | |
DAA269 | alpha-kinase 2 | Molecular | kidney | Human | ALPK2 | 20.0% Increase Gene Expression Level | |
DAA267 | amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein | Molecular | kidney | Human | APBB1IP | 23.0% Increase Gene Expression Level | |
DAA604 | Cancer of kidney and renal pelvis | Pathological | urinary system | Human | — | SeriesMorbidity |